Effects of Meal and Exercise Sequence on Glucose and Blood Pressure Responses

April 29, 2025 updated by: Yung-Chih Chen, National Taiwan Normal University
The purpose of this study is to investigate whether the sequence meal and exercise (exercise before meal or exercise after meal) affects the postprandial metabolism.

Study Overview

Detailed Description

Trial days In the 24 h prior to each main trial, participants were asked to refrain from performing any strenuous physical activity and from consuming alcohol/caffeine. Dinner intake was recorded before the first main trial and participants were asked to replicate this diet prior to their second main trial.

On main trial days, participants arrived at the laboratory between 8-9 am following a 10-hour fast. After measuring height, blood pressure, pulse, and obtaining finger-prick blood samples, participants underwent EM or ME intervention.

The entire experiment lasted a total of 150 minutes. During the initial 50 minutes, participants were randomly assigned to either exercise before or after breakfast. Participants were asked to finish their breakfast within approximately 5 minutes. The exercise regimen consisted of brisk walking for 22 minutes at a speed of 6 km/hr on the indoor track. After a 25-minute break, the second meal was provided. Participants then underwent a 75-minute observation period during the postprandial phase. Blood pressure and pulse were assessed with the individual seated in a relaxed, upright position on a chair, with the arm properly positioned. Two measurements of blood pressure and pulse were taken, and these values were averaged to ensure that the two readings were within 5 mmHg of each other. If the two readings differed by more than 5 mmHg, additional readings were taken until the outlying measurement was excluded. The test meal consists of red bean dorayaki (CHUAN LIAN Enterprise Co., Ltd.) and soy milk (I-MEI Foods Co., Ltd.). The breakfast provided contained 348 kcal, with a macronutrient distribution of 60% carbohydrates, 12% protein, and 28% fat. The second meal contained 207 kcal, with a macronutrient distribution of 66% carbohydrates, 6% protein, and 28% fat.

Finger-prick blood samples, blood pressure, and pulse were measured every 25 minutes during the experiment using the Freestyle Optium Neo (Abbott Diabetes Care, Ltd., UK) and the OMRON HEM-7320 blood pressure monitor (OMRON Co., Ltd., Japan). Two measurements of blood pressure and pulse were taken, and these values were averaged to ensure that the two readings were within 5 mmHg of each other. If the two readings differed by more than 5 mmHg, additional readings were taken until the outlying measurement was excluded. Blood pressure and pulse were assessed with the individual seated in a relaxed, upright position on a chair, with the arm properly positioned.

Study Type

Interventional

Enrollment (Actual)

18

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taipei, Taiwan
        • National Taiwan Normal University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Age between 20 and 45 years
  2. Body Mass Index (BMI) ranging from 18.5 to 27 kg/m2
  3. No habits of heavy drinking or smoking, or have quit smoking for at least 6 months
  4. Absence of diabetes, cardiovascular, or metabolic-related disorders
  5. Not currently taking medications, or other supplements that may affect blood sugar, blood pressure, or metabolic changes
  6. No current sports injuries or medical advice against exercise
  7. No significant weight fluctuations in the past three months (within ±3% of usual body weight)
  8. Not experiencing shift work or travel across time zones within the past 6 months
  9. No current plans to change lifestyle habits and willing to adhere to the requirements of the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Meal-Exercise
Breakfast intake before 22 minutes of brisk walking
Breakfast intake before 22 minutes of brisk walking, followed by a lunch intake for another 75 minutes of observation period. The entire experiment lasted a total of 150 minutes.
Experimental: Exercise-Meal
22 minutes of brisk walking before breakfast intake
22 minutes of brisk walking before breakfast intake, followed by 75 minutes of observational period. The entire experiment lasted a total of 150 minutes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postprandial glucose concentrations
Time Frame: 150 minutes
Changes in glucose responses during trials
150 minutes
Blood pressure
Time Frame: 150 minutes
Changes in blood pressure (e.g., diastolic and systolic blood pressure) during trials
150 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 24, 2023

Primary Completion (Actual)

January 9, 2024

Study Completion (Actual)

January 9, 2024

Study Registration Dates

First Submitted

April 22, 2025

First Submitted That Met QC Criteria

April 22, 2025

First Posted (Actual)

April 29, 2025

Study Record Updates

Last Update Posted (Actual)

May 2, 2025

Last Update Submitted That Met QC Criteria

April 29, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Blood Pressure

Clinical Trials on Meal-Exercise

Subscribe